A Study of V330 in Healthy Younger and Healthy Older Participants
Completed
Trial Purpose
The goal of this study is to learn whether a new vaccine, V330, is safe and learn how well the body’s immune system responds by making antibodies after receiving V330.
View full trial information on Clinicaltrials.gov
 |
National Trial Reference Number | NCT06630117 |
 |
MSD Protocol ID |
|
 |
Conditions |
Healthy |
 |
Age Range |
18 – 79 |
 |
Sex | ALL |
 |
Trial Phase | 1 |
 |
Start Date End Date |
2024-03-01 2025-10-17 |
Study Details
Patient Participation
Only a qualified healthcare professional can determine if you are eligible to take part in a clinical trial.
Conditions
Healthy
Trial Phase 1
Investigational medication is tested for safety on a relatively small group of 20 to 100 volunteers who are usually healthy, but not always. Phase 1 trials may happen in a doctor’s office or a hospital.
Trial Locations
Locations shown may have changed in some cases. Please call the number listed in the location results to confirm the nearest trial site. Talk with a trial site member for more information.
Sorry, there are no locations found.
What can you do next?
If you think this clinical trial might be a good fir and you are interested in taking part, take the next step to see if you are eligible.
Discuss with your doctor or care team
Print this page with details about the trial or email it to your doctor to discuss the clinical trial during your next visit.
To learn more, call 1-888-577-8839